Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin
详细信息 查看全文
- 作者：Ai-Li Shiau (1)
Min-Li Teo (1)
Shin-Yao Chen (2)
Chrong-Reen Wang (3)
Jeng-Long Hsieh (4)
Meng-Ya Chang (5)
Chih-Jui Chang (6)
Julie Chao (7)
Lee Chao (7)
Chao-Liang Wu (2)
Che-Hsin Lee (8) - 刊名：BMC Cancer
- 出版年：2010
- 出版时间：December 2010
- 年：2010
- 卷：10
- 期：1
- 全文大小：1242KB
- 参考文献：1. Chen LM, Chao L, Chao J: Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats. / Hum Gene Ther 1997, 8:341-47. CrossRef
2. Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, Chao J: Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. / Arthritis Rheum 2005, 52:1319-324. CrossRef
3. Zhu B, Lu L, Cai W, Yang X, Li C, Yang Z, Zhan W, Ma JX, Gao G: Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis. / Mol Cancer Ther 2007, 6:3297-306. CrossRef
4. Lu L, Yang Z, Zhu B, Fang S, Yang X, Cai W, Li C, Ma JX, Gao G: Kallikrein-binding protein suppresses growth of hepatocellular carcinoma by anti-angiogenic activity. / Cancer Lett 2007, 257:97-06. CrossRef
5. Miao RQ, Agata J, Chao L, Chao J: Kallistatin is a new inhibitor of angiogenesis and tumor growth. / Blood 2002, 100:3245-252. CrossRef
6. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ: Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. / J Natl Cancer Inst 2002, 94:1134-142.
7. Chao J, Yin H, Yao YY, Shen B, Smith RS Jr, Chao L: Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. / Hum Gene Ther 2006, 17:1201-213. CrossRef
8. Hsieh JH, Shen PC, Shiau AL, Jou IM, Lee CH, Teo ML, Wang CR, Chao J, Chao L, Wu CL: Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. / Hum Gene Ther 2009, 20:147-58. CrossRef
9. Lee CH, Wu CL, Shiau AL: Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma. / Int J Cancer 2008, 122:930-35. CrossRef
10. Lee CH, Wu CL, Shiau AL: Toll-like receptor 4 signaling promotes tumor growth. / J Immunother 2010, 33:73-2. CrossRef
11. Wang CR, Chen SY, Shiau AL, Wu CL, Jou IM, Chao L, Chao J: Upregulation of kallistatin expression in rheumatoid joints. / J Rheumatol 2007, 34:2171-176.
12. Lee CH, Wu CL, Shiau AL: Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis . / Clin Cancer Res 2008, 14:1905-912. CrossRef
13. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J: Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. / Gene Ther 1999, 6:715-28. CrossRef
14. Indraccolo S, Tisato V, Tosello V, Habeler W, Esposito G, Moserle L, Stievano L, Persano L, Chieco-Bianchi L, Amadori A: Interferon-α gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition. / Hum Gene Ther 2005, 16:957-70. CrossRef
15. Robinson-Smith TM, Isaacsohn I, Mercer CA, Zhou M, Van Rooijen N, Husseinzadeh N, McFarland-Mancini MM, Drew AF: Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. / Cancer Res 2007, 67:5708-716. CrossRef
16. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. / Trends Immunol 2004, 25:677-86. CrossRef
17. Lee CH, Wu CL, Shiau AL: Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. / J Gene Med 2004, 6:1382-393. CrossRef
18. Lee CH, Wu CL, Shiau AL: Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. / Cancer Gene Ther 2005, 12:175-84. CrossRef
19. Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. / Nat Rev Cancer 2008, 8:592-03. CrossRef
20. Lemiale F, Asefa B, Ye D, Chen C, Korokhov N, Humeau L: An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization. / Vaccine 2010, 28:1952-961. CrossRef
21. He Y, Zhang J, Donahue C, Falo LD Jr: Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. / Immunity 2006, 24:643-56. CrossRef
22. Chai KX, Ward DC, Chao J, Chao L: Molecular cloning, sequence analysis, and chromosomal localization of the human protease inhibitor 4 (kallistatin) gene (PI4). / Genomics 1994, 23:370-78. CrossRef
23. Chai KX, Ma JX, Murray SR, Chao J, Chao L: Molecular cloning and analysis of the rat kallikrein-binding protein gene. / J Biol Chem 1991, 266:16029-6036.
24. Chao J, Schmaier A, Chen LM, Yang Z, Chao L: Kallistatin, a novel human tissue kallikrein inhibitor: Levels in body fluids, blood cells, and tissues in health and disease. / J Lab Clin Med 1996, 127:612-20. CrossRef
25. Tse LY, Sun X, Jiang H, Dong X, Fung PW, Farzaneh F, Xu R: Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas. / J Gene Med 2008, 10:508-17. CrossRef
26. Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK: Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. / Cancer Res 2004, 64:3731-736. CrossRef
27. Jiang X, Li H, Qiao H Jiang H, Xu R, Sun X: Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. / Cancer Sci 2009, 100:2226-233. CrossRef
28. Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y: Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. / Cancer Res 2000, 60:5565-570.
29. Teicher BA, Holden SA, Ara G, Dupuis NP, Liu F, Yuan J, Ikebe M, Kakeji Y: Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. / Int J Cancer 1995, 61:732-37. CrossRef
30. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M: Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNF-α to TRAIL-mediated tumor regression. / Cancer Cell 2004, 6:297-05. CrossRef
31. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M: Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. / Nature 2009, 457:102-06. CrossRef
32. Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM: Angiostatin suppresses malignant glioma growth in vivo . / Cancer Res 1998, 58:4654-659.
33. Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, Bajou K, Fong T, Chiang Y, Foidart JM, No?l A: The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. / FASEB J 2002, 16:1802-804.
34. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/10/245/prepub - 作者单位：Ai-Li Shiau (1)
Min-Li Teo (1)
Shin-Yao Chen (2)
Chrong-Reen Wang (3)
Jeng-Long Hsieh (4)
Meng-Ya Chang (5)
Chih-Jui Chang (6)
Julie Chao (7)
Lee Chao (7)
Chao-Liang Wu (2)
Che-Hsin Lee (8)
1. Department of Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan
2. Department of Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan
3. Section of Rheumatology, Department of Internal Medicine, National Cheng Kung University Medical College, Tainan, Taiwan
4. Department of Nursing, Chung Hwa University of Medical Technology, Tainan Hsien, Taiwan
5. Graduate Institute of Clinical Medicine, Tzu Chi University, Hualien, Taiwan
6. Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien, Taiwan
7. Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, USA
8. Department of Microbiology, School of Medicine, China Medical University, Taichung, Taiwan - ISSN：1471-2407
文摘
Background Angiogenesis plays an important role in the development and progression of tumors. Kallistatin exerts anti-angiogenic and anti-inflammatory activities that may be effective in inhibiting tumor metastasis. We investigated the antitumor effect of lentivirus-mediated kallistatin gene transfer in a syngeneic murine tumor model. Methods Lentiviral vector encoding kallistatin (LV-Kallistatin) was constructed. The expression of kallistatin was verified by enzyme-linked immunosorbent assay (ELISA), and the bioactivity of kallistatin was determined by using cell proliferation, migration, and invasion assays. In addition, antitumor effects of LV-Kallistatin were evaluated by the intravenous injection of virus into tumor-bearing mice. Results The conditioned medium from LV-Kallistatin-treated cells inhibited the migration and proliferation of endothelial cells. Meanwhile, it also reduced the migration and invasion of tumor cells. In the experimental lung metastatic model, tumor-bearing mice receiving LV-Kallistatin had lower tumor nodules and longer survival than those receiving control virus or saline. Moreover, the microvessel densities, the levels of vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-α, and nuclear factor κB (NF-κB) transcriptional activity were reduced in the LV-Kallistatin-treated mice. Conclusion Results of this study showed that systemic administration of lentiviral vectors encoding kallistatin inhibited the growth of metastatic tumor and prolonged the survival of tumor-bearing mice. These results suggest that gene therapy using lentiviruses carrying the kallistatin gene, which exerts anti-angiogenic and anti-inflammatory activities, represents a promising strategy for the treatment of lung cancer.